Focus
Shaping the future of diagnostics David Wells – Chief Executive, Institute of Biomedical Science
Biomedical science is evolving rapidly – shaped by digital transformation, new testing technologies, and growing demand for faster, more equitable diagnostics. Across this changing landscape, the IBMS is ensuring that biomedical scientists remain recognised, supported, and central to how healthcare delivers for patients. Every stage of a biomedical scientist’s
career is now defined by the standards and qualifications set by the Institute. From accredited university degrees to the completion of IBMS Registration Portfolios, the Institute safeguards routes to Health and Care Professions Council (HCPC) registration and ensures that those entering the workforce meet the highest levels of scientific and professional competence. This gives patients, employers, and regulators the assurance that diagnostic services are delivered by experts who are accountable and trusted. The IBMS continues to strengthen the
profession’s position in national workforce and diagnostics policy. By providing evidence, expertise, and leadership to the NHS, government, and partner organisations, the Institute is helping shape decisions about diagnostic capacity, workforce sustainability, and service design. This work ensures that biomedical scientists, clinical scientists and laboratory staff are properly recognised in discussions that affect patient access and the future of healthcare delivery. Professional development remains a
cornerstone of this influence. Through our specialist, higher and advanced qualifications, the IBMS gives members clear routes to recognition and progression.
THE BIOMEDICAL SCIENCE INDUSTRY HANDBOOK 2026 l 7
Biomedical scientists are now achieving advanced and consultant- level practice through the Institute’s frameworks – bringing scientific leadership into multidisciplinary
teams and reinforcing the value of biomedical expertise across healthcare systems. Collaboration with industry continues to amplify this impact. Company membership creates structured partnerships that connect technology developers with the profession’s scientific insight and experience. These collaborations are helping ensure that innovation is introduced safely, effectively, and in line with the realities of patient testing and laboratory practice. Today, biomedical scientists are shaping the future of healthcare. The IBMS stands with them – ensuring their expertise drives innovation, informs policy, and secures the standards that keep patients safe. Through its members and partners, the Institute continues to define what excellence in diagnostics means for the UK.
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86
